Chantix (varenicline) is the latest option for smoking cessation

August 2006

Chantix (varenicline) is the latest option for smoking cessation.

It's the first PARTIAL nicotine agonist. It binds to nicotine receptors...but stimulates them less than nicotine.

This partial nicotine effect helps ease withdrawal symptoms.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

the risk of jaw bone damage while taking Fosamax or other bisphosphonates
Cardiology Zocor and the new generic simvastatins
Cardiology guidelines to help determine which patients should be STARTED on beta-blockers before non-cardiac surgery
Vaccines CDC will soon recommend a booster of the chickenpox vaccine
Vaccines shortage of Menactra (meningococcal vaccine)
Neurology & Pain two new ORAL forms of oxymorphone called Opana and Opana ER
Diabetes New "guidelines" for treating pain due to diabetic peripheral neuropathy
Infectious Diseases several changes in HIV drug therapy
Women's Health new oral contraceptive called Seasonique
Women's Health prenatal vitamins with DHA
treatment options for eating disorders
Hematology & Oncology Sprycel (dasatinib), a new oral drug for certain forms of leukemia
Hematology & Oncology Cesamet (nabilone) is a new option for nausea and vomiting associated with chemotherapy
Smoking Cessation Chantix (varenicline) is the latest option for smoking cessation